ArticleInternational journal of oncology2018

COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.

Zheying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.